News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Actis, Sequoia Pharmaceuticals Said to Plan Sale of Stake in Paras Pharmaceuticals Ltd. for Up to $700 Million


9/7/2010 8:16:22 AM

Bloomberg -- Actis Capital LLP and Sequoia Capital plan to sell a controlling stake in India’s Paras Pharmaceuticals Ltd. for as much as $700 million, according to three people with direct knowledge of the matter.

Read at Bloomberg

comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES